Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico. 2020

Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
Leicester School of Pharmacy, De Montfort University, Leicester, UK.

BACKGROUND Tyrosinase is a multifunctional copper-containing oxidase enzyme that catalyses the first steps in the formation of melanin pigments. Identification of tyrosinase inhibitors is of value for applications in cosmetics, medicine and agriculture. OBJECTIVE To develop an analytical method that allows identification of drug-like natural products that can be further developed as tyrosinase inhibitors. Results of in vitro and in silico studies will be compared in order to gain a deeper insight into the mechanism of action of enzyme inhibition. METHODS Using an in vitro assay we tested tyrosinase inhibitor effects of five structurally related flavones, i.e. luteolin (1), eupafolin (2), genkwanin (3), nobiletin (4), and chrysosplenetin (5). The strongest inhibitors were further investigated in silico, using enzyme docking simulations. RESULTS All compounds tested showed modest tyrosinase inhibitory effect compared to the positive control, kojic acid. The polymethoxy flavones 4 and 5 exhibited the strongest tyrosinase inhibitory effect with the half maximal inhibitory concentration (IC50 ) values of 131.92 ± 1.75 μM and 99.87 ± 2.38 μM respectively. According to kinetic analysis 2, 4 and 5 were competitive inhibitors, whereas 1 and 3 were non-competitive inhibitors of tyrosinase. Docking studies indicated that methoxy groups on 4 and 5 caused steric hindrance which prevented alternative binding modes in the tyrosinase; the methoxy groups on the B-ring of these flavones faced the catalytic site in the enzyme. CONCLUSIONS The docking simulations nicely complemented the in vitro kinetic studies, opening the way for the development of predictive models for use in drug design.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000363 Agaricales An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms. Agaricaceae,Mushrooms,Agaricale,Mushroom
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D047309 Flavones A group of 4-keto-FLAVONOIDS. 2-Phenyl-2-Ene-Benzopyran-4-One Compounds
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
December 2024, Journal of enzyme inhibition and medicinal chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
June 2015, European journal of medicinal chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
March 2023, International journal of molecular sciences,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
February 2019, Bioorganic chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
October 2020, Bioorganic chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
May 2023, ACS omega,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
September 2023, Future medicinal chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
May 2022, ACS omega,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
October 2023, Food chemistry,
Randolph R J Arroo, and Suat Sari, and Burak Barut, and Arzu Özel, and Ketan C Ruparelia, and Didem Şöhretoğlu
April 2021, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!